Home / Stocks / MAZE

MAZE insider trading

Maze Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy
—

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-03-12Bernstein Harold
President, R&D & CMO
Sold29,652$50.45$1.5M
2026-01-09Bernstein Harold
President, R&D & CMO
Sold25,156$40.20$1.0M
2026-01-08Sohn Catherine A.
Director
Sold26,920$39.11$1.1M
2025-12-31Dandekar Atul
CSBO
Sold66,365$40.51$2.7M
2025-12-31Bernstein Harold
President, R&D & CMO
Sold27,800$40.34$1.1M

See MAZE on the chart

Every insider buy and sell for MAZE plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.